Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hotta

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Experimental Eye Research|September 7, 2000
Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytesK Naruse, J Nakamura, Y Hamada, et al.
Japanese Journal of Pharmacology|March 19, 1999
Central nervous system-mediated hyperglycemic effects of NIK-247, a cholinesterase inhibitor, and MKC-231, a choline uptake enhancer, in ratsK Uemura, S Yoshioka, D M Surina-Baumgartner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1996
Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized studyT Sano, N Hotta, T Kawamura, et al.
European Journal of Clinical Investigation|December 1, 1995
An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic ratsN Hotta, N Koh, F Sakakibara, et al.
Diabetologia|September 3, 1998
The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion moleculesT Kawamura, T Umemura, A Kanai, et al.
Prostaglandins|June 1, 1995
Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic ratsN Hotta, N Koh, F Sakakibara, et al.
European Journal of Pharmacology|December 27, 1995
Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in ratsJ Nakamura, N Koh, F Sakakibara, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 23, 2008
Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestatN Hotta, R Kawamori, Y Atsumi, et al.
Life Sciences|March 27, 1998
A new spontaneous animal model of NIDDM without obesity in the musk shrewT Ohno, F Yoshida, Y Ichikawa, et al.
Diabetes Research and Clinical Practice|February 1, 1995
Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in ratsN Hotta, H Kakuta, H Fukasawa, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Experimental Eye Research|September 7, 2000
Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytesK Naruse, J Nakamura, Y Hamada, et al.
Japanese Journal of Pharmacology|March 19, 1999
Central nervous system-mediated hyperglycemic effects of NIK-247, a cholinesterase inhibitor, and MKC-231, a choline uptake enhancer, in ratsK Uemura, S Yoshioka, D M Surina-Baumgartner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1996
Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized studyT Sano, N Hotta, T Kawamura, et al.
European Journal of Clinical Investigation|December 1, 1995
An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic ratsN Hotta, N Koh, F Sakakibara, et al.
Diabetologia|September 3, 1998
The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion moleculesT Kawamura, T Umemura, A Kanai, et al.
Prostaglandins|June 1, 1995
Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic ratsN Hotta, N Koh, F Sakakibara, et al.
European Journal of Pharmacology|December 27, 1995
Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in ratsJ Nakamura, N Koh, F Sakakibara, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 23, 2008
Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestatN Hotta, R Kawamori, Y Atsumi, et al.
Life Sciences|March 27, 1998
A new spontaneous animal model of NIDDM without obesity in the musk shrewT Ohno, F Yoshida, Y Ichikawa, et al.
Diabetes Research and Clinical Practice|February 1, 1995
Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in ratsN Hotta, H Kakuta, H Fukasawa, et al.
Pageof 17